Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Precursor Cell Lymphoblastic Leukemia-Lymphoma × durvalumab × 90 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 38 Lung Neoplasms 25 Small Cell Lung Carcinoma 18 Carcinoma, Hepatocellular 18 Urinary Bladder Neoplasms 10 Liver Neoplasms 9 Biliary Tract Neoplasms 9 Neoplasms 6 Stomach Neoplasms 5 Cholangiocarcinoma 5 Breast Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 4 Ovarian Neoplasms 4 Carcinoma 4 Triple Negative Breast Neoplasms 3 Respiratory Tract Neoplasms 3 Neoplasms by Site 3 Endometrial Neoplasms 3 Colorectal Neoplasms 3 Carcinoma, Transitional Cell 3 Adenocarcinoma 3 Uterine Cervical Neoplasms 2 Thoracic Neoplasms 2 Respiratory Tract Diseases 2 Pathologic Complete Response 2 Pancreatic Neoplasms 2 Oropharyngeal Neoplasms 2 Neoplasm Metastasis 2 Mouth Neoplasms 2 Mesothelioma, Malignant 2

Interventions

Cyclophosphamide 38 fludarabine 24 Methotrexate 21 Vincristine 20 Cytarabine 18 fludarabine phosphate 17 blinatumomab 17 Dexamethasone 16 venetoclax 11 Melphalan 11 Granulocyte Colony-Stimulating Factor 11 Whole-Body Irradiation 10 Mycophenolic Acid 10 Mercaptopurine 10 Tacrolimus 9 Hydrocortisone 9 Filgrastim 9 Stem Cell Transplantation 8 Rituximab 8 Mesna 8 Etoposide 8 Doxorubicin 8 Calcium Dobesilate 8 Busulfan 8 pegaspargase 7 merphos 7 calaspargase pegol 7 Specimen Handling 7 Magnetic Resonance Spectroscopy 7 ponatinib 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡